Ensign Peak Advisors
IMUX icon

Ensign Peak Advisors’s Immunic IMUX Stock Holding History

Ensign Peak Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,361
Closed -$297K – 2214
2021
Q3 		$297K Sell
3,361
-5,839
-63% -$575K ﹤0.01% 1706
2021
Q2 		$1.13M Hold
9,200
– – ﹤0.01% 1399
2021
Q1 		$1.47M Hold
9,200
– – ﹤0.01% 1258
2020
Q4 		$1.41M Hold
9,200
– – ﹤0.01% 1248
2020
Q3 		$1.71M Buy
+9,200
New +$1.51M ﹤0.01% 1054

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ensign Peak Advisors's IMUX Position: Q4 2021 in Review

Ensign Peak Advisors sold out of Immunic (IMUX) in Q4 2021, closing a stake of 3,361 shares — an estimated $297K sold.

Ensign Peak Advisors first reported a position in IMUX in Q3 2020 and held it in 5 quarters. The position peaked at $1.71M in Q3 2020. 67 funds tracked by Wall St. Rank hold IMUX as of Q4 2021.

  • Ensign Peak Advisors reported no remaining Immunic position as of Q4 2021 after selling out during the quarter.
  • Ensign Peak Advisors sold 3,361 Immunic shares in Q4 2021, an estimated $297K.
  • Ensign Peak Advisors first reported a position in Immunic in Q3 2020 and held it in 5 quarters.
  • Ensign Peak Advisors's Immunic position peaked at $1.71M in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Immunic as of Q4 2021.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.